Eli Lilly is a global pharmaceutical company striving to improve patients' lives and make essential treatments accessible.
Since its founding in 1876, Lilly has been committed to producing high-quality medications that address real needs.
Even after 147 years, the company and its employees remain dedicated to the vision of "take what we have here and make it better and better," whether through developing and providing access to innovative medications, or through activities and initiatives for the patient community and their families.
Research and development focus on the fields of diabetes and obesity, oncology, hemato-oncology, dermatology, rheumatology, gastroenterology, and Alzheimer's disease.
Haverim L'Refuah thanks Eli Lilly for donating oncology medications to patients in Israel who need them.
